Prof. Harry Janssen
Harry Janssen (1964) graduated from medical school at the Radboud University of Nijmegen, the Netherlands. During his study he spent one year as research fellow in Hepatology at the Mayo Clinic. He obtained his PhD in Rotterdam on the role of immune modulating therapy in chronic hepatitis B. He then trained in Internal Medicine at Leiden University Medical Center and in Gastroenterology & Hepatology at Rotterdam Erasmus University Medical Center. Following his registration as Gastroenterologist he returned to the Mayo Clinic for a research fellowship in Hepatology at the Center of Basic Research in Digestive Diseases. In 2001 he became a staff member and in 2006 he was appointed as full professor of Hepatology and chief of the Section Liver Diseases and Transplantation in Rotterdam.
As principle investigator prof. Janssen coordinated numerous European and global multicenter studies on antiviral treatment for chronic viral hepatitis. He was awarded a Clinical Fellowship and an Innovational Research grant (VIDI) from the Netherlands Organisation of Scientific Research (NWO) to study strategies of immune control in viral hepatitis and published many international articles on this subject. Professor Janssen is chairman of the Dutch Association of Hepatology and was elected as Rising Star in Gastroenterology and Hepatology by the Association of the National European Societies of Gastroenterology. He has been member of the editorial board of Hepatology, Journal of Hepatology and Best Practice in Gastroenterology. He has published over 200 original peer-reviewed papers. In addition to his longstanding expertise in antiviral therapy of chronic viral hepatitis, professor Janssen is a leading scientist in the field of vascular disorders of the liver.